drug
as of 2026-07-01Nicotine patch
Nicotine Patch
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Centre for Addiction and Mental Health
7 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
7
Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings
NCT05030272—Completed
Evoked Responses as Pharmacodynamic Biomarkers in Healthy and Schizophrenic Participants (MK-4334-007)
NCT05136690Phase 1Completed
Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI)
NCT03873337—Completed
Treating Smokers With Mental Illness
NCT03822416Phase 2Completed
E-cigarettes to Promote Smoking Reduction Among Individuals With Schizophrenia
NCT02918630—Completed
Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophrenia
NCT00407277—Completed
Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1
NCT00046813Phase 4Terminated
KOLs & investigators
6
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
trial
indication
indication
indication
indication
KOL
Marc L. Steinberg, PH.D.
personKOL score 5
Jeff Daskalakis, MD, PhD
personKOL score —
Jin Ho Yoon, PhD
personKOL score —
Harry Lando, PhD
personKOL score —